Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Enhertu“
Suchtreffer
Begriffe & Kennungen
Enhertu · 4.8 · Dose interruptions due to adverse reactions occurred in 40.7% of patients treated with Enhertu. The most frequ
Eintrag öffnenEnhertu · 4.8 · Dose interruptions due to adverse reactions occurred in 54.1% of patients treated with Enhertu 5.4 mg/kg in co
Eintrag öffnenEnhertu · 4.8 · Enhertu 5.4 mg/kg The pooled safety population has been evaluated for patients who received at least one dose
Eintrag öffnenEnhertu · 4.8 · Enhertu 5.4 mg/kg in combination with pertuzumab
Eintrag öffnenEnhertu · 4.8 · Enhertu 5.4 mg/kg in combination with pertuzumab In patients treated with Enhertu 5.4 mg/kg in combination wit
Eintrag öffnenEnhertu · 4.8 · Enhertu 5.4 mg/kg in combination with pertuzumab In patients treated with Enhertu 5.4 mg/kg in combination wit
Eintrag öffnenEnhertu · 4.8 · Enhertu 5.4 mg/kg in combination with pertuzumab In patients treated with Enhertu 5.4 mg/kg in combination wit
Eintrag öffnenEnhertu · 4.8 · Enhertu 5.4 mg/kg in combination with pertuzumab In patients treated with Enhertu 5.4 mg/kg in combination wit
Eintrag öffnenEnhertu · 4.8 · Enhertu 5.4 mg/kg in combination with pertuzumab In patients treated with Enhertu 5.4 mg/kg in combination wit
Eintrag öffnenEnhertu · 4.8 · Enhertu 6.4 mg/kg The pooled safety population has been evaluated for patients who received at least one dose
Eintrag öffnenEnhertu · 4.8 · Enhertu as monotherapy
Eintrag öffnenEnhertu · 4.8 · Enhertu as monotherapy In patients treated with Enhertu 5.4 mg/kg in clinical studies (n = 3057) across multip
Eintrag öffnenEnhertu · 4.8 · Enhertu as monotherapy In patients treated with Enhertu 5.4 mg/kg in clinical studies (n = 3057) across multip
Eintrag öffnenEnhertu · 4.8 · Enhertu as monotherapy In patients treated with Enhertu 5.4 mg/kg in clinical studies across multiple tumour t
Eintrag öffnenEnhertu · 4.8 · Enhertu as monotherapy In patients treated with Enhertu 5.4 mg/kg in clinical studies across multiple tumour t
Eintrag öffnenEnhertu · 4.8 · Enhertu as monotherapy In patients treated with Enhertu 5.4 mg/kg in clinical studies across multiple tumour t
Eintrag öffnenEnhertu · 4.8 · Ethnic differences
Eintrag öffnenEnhertu · 4.8 · Immunogenicity
Eintrag öffnenEnhertu · 4.8 · In clinical studies, no relevant differences in exposure or efficacy were observed between patients of differe
Eintrag öffnenEnhertu · 4.8 · In patients treated with Enhertu 6.4 mg/kg in clinical studies (n = 1133) across multiple tumour types, infusi
Eintrag öffnen